Physician

Oncology

Dr. Lee S. Scheinbart, MD

Scheinbart works in the field of Oncology. He attended The Ohio State University College of Medicine. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Lee S. Scheinbart, MD is a published doctor. He has 2 papers published. The most current publication "Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis." He accepts all Medicare patients.

Publications

Evidence for impaired T cell DNA methylation in Systemic lupus erythematosus and rheumatoid arthritis.
Procainamide inhibits DNA methyltransferase in a human T Cell line.

Schools

Ohio State University College of Medicine
Shands Hospital University Fla

Procedures Preformed

Thoracentesis

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Awards

Meaningful Use Stage 1 Certification

Education

University of Florida
The Ohio State University College of Medicine

Drug Facts

NPI NUMBER		1063497592
NPPES Provider LastName		SCHEINBART
NPPES Provider FirstName		LEE
NPPES Provider ZIPCode		329011946
NPPES Provider State		FL
Specialty Description		Hematology/Oncology
Total Claim Count		1245.0
Distinct Opioid Count		4.0
Opioid Claim Count		145.0
Percent Opioid Claims		11.65

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1063497592
Last Name Of The Provider	SCHEINBART
First Name Of The Provider	LEE
View All

Similar Doctors

	Dr. Craig J. Badolato, MD This Doctor is OpenDoctor Recommended.
	Dr. Sumeet Chandra, MD This Doctor is OpenDoctor Recommended.
	Dr. Noor M. Merchant, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig K. Deligdish, MD This Doctor is OpenDoctor Recommended.